retatrutide triple hormone receptor agonist retatrutide is a triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing Retatrutide - Medshape Weight Loss

Clinical observations from practitioners using microdosed GLP-1 in Hashimoto patients report improvements in thyroid antibody levels (TPO and thyroglobulin antibodies) and reductions in thyroid-related fatigue

Mediation analysis We assessed the effects of GLP-1RAs on established risk factors for SA, including BMI, current tobacco smoking, and alcohol consumption, and found associations between all these factors and both GLP-1RAs and SA

Frank helped speed up my recovery process from an ankle injury with PRP

The choice between oral and injectable BPC-157 depends on your specific therapeutic goals, lifestyle factors, and comfort with injection protocols

Never self-start supplements while breastfeeding